FR2670674B1 - Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1. - Google Patents

Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1.

Info

Publication number
FR2670674B1
FR2670674B1 FR9115879A FR9115879A FR2670674B1 FR 2670674 B1 FR2670674 B1 FR 2670674B1 FR 9115879 A FR9115879 A FR 9115879A FR 9115879 A FR9115879 A FR 9115879A FR 2670674 B1 FR2670674 B1 FR 2670674B1
Authority
FR
France
Prior art keywords
compound
pharmaceutical compositions
compositions containing
agonist activity
selective agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9115879A
Other languages
English (en)
Other versions
FR2670674A1 (fr
Inventor
Alain Emile Edouard Schaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoires Glaxo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA filed Critical Laboratoires Glaxo SA
Publication of FR2670674A1 publication Critical patent/FR2670674A1/fr
Application granted granted Critical
Publication of FR2670674B1 publication Critical patent/FR2670674B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9115879A 1990-12-21 1991-12-20 Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1. Expired - Fee Related FR2670674B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (2)

Publication Number Publication Date
FR2670674A1 FR2670674A1 (fr) 1992-06-26
FR2670674B1 true FR2670674B1 (fr) 1994-05-13

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9115879A Expired - Fee Related FR2670674B1 (fr) 1990-12-21 1991-12-20 Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1.

Country Status (25)

Country Link
EP (1) EP0563094B1 (fr)
JP (1) JP3425949B2 (fr)
KR (1) KR100188172B1 (fr)
AT (1) ATE127688T1 (fr)
AU (1) AU654313B2 (fr)
BE (1) BE1004182A3 (fr)
CA (1) CA2099585C (fr)
CH (1) CH684161A5 (fr)
CZ (1) CZ281042B6 (fr)
DE (1) DE69113062T2 (fr)
DK (1) DK0563094T3 (fr)
ES (1) ES2078727T3 (fr)
FR (1) FR2670674B1 (fr)
GB (2) GB9027827D0 (fr)
GR (1) GR3017701T3 (fr)
HK (1) HK18795A (fr)
IE (1) IE914482A1 (fr)
IL (1) IL100452A (fr)
IT (1) IT1252599B (fr)
MX (1) MX9102733A (fr)
NZ (1) NZ241098A (fr)
RU (1) RU2110992C1 (fr)
SG (1) SG169594G (fr)
WO (1) WO1992011003A1 (fr)
ZA (1) ZA9110052B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
IL100452A (en) 1997-02-18
AU654313B2 (en) 1994-11-03
CZ281042B6 (cs) 1996-06-12
KR100188172B1 (ko) 1999-06-01
GR3017701T3 (en) 1996-01-31
EP0563094A1 (fr) 1993-10-06
EP0563094B1 (fr) 1995-09-13
CA2099585C (fr) 2003-09-30
GB2250917B (en) 1994-10-26
JPH06503826A (ja) 1994-04-28
NZ241098A (en) 1993-07-27
DE69113062D1 (de) 1995-10-19
FR2670674A1 (fr) 1992-06-26
DE69113062T2 (de) 1996-02-01
IE914482A1 (en) 1992-07-01
ATE127688T1 (de) 1995-09-15
ZA9110052B (en) 1992-10-28
WO1992011003A1 (fr) 1992-07-09
GB9126957D0 (en) 1992-02-19
CZ122593A3 (en) 1994-02-16
BE1004182A3 (fr) 1992-10-06
GB2250917A (en) 1992-06-24
IL100452A0 (en) 1992-09-06
GB9027827D0 (en) 1991-02-13
ITRM910963A0 (it) 1991-12-20
MX9102733A (es) 1992-09-01
ES2078727T3 (es) 1995-12-16
AU9066591A (en) 1992-07-22
CH684161A5 (fr) 1994-07-29
SG169594G (en) 1995-04-28
CA2099585A1 (fr) 1992-06-22
DK0563094T3 (da) 1995-12-04
IT1252599B (it) 1995-06-19
JP3425949B2 (ja) 2003-07-14
HK18795A (en) 1995-02-17
RU2110992C1 (ru) 1998-05-20
ITRM910963A1 (it) 1993-06-20

Similar Documents

Publication Publication Date Title
ES2091877T3 (es) Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia.
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
ES2181866T3 (es) Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2083119T3 (es) Comprimido matricial que permite la liberacion prolongada de indapamida despues de su administracion por via oral.
ES2163461T3 (es) Procedimiento para la obtencion de comprimidos efervescentes.
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
SE8804628D0 (sv) New compounds
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ES2064166T3 (es) Composiciones conteniendo propionato de fluticasona y oxiconazol o sus sales para administracion topica.
FR2670674B1 (fr) Compositions pharmaceutiques contenant un compose a activite agoniste selective aux recepteurs analogues a la 5-ht1.
ES2135412T3 (es) Uso de antagonistas o agonistas parciales del receptor 5-ht 1a para el tratamiento y la prevencion de trastornos cognitivos.
DE3875611T2 (de) Pharmazeutische zusammensetzungen.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
DK0552712T3 (da) 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer
KR900701262A (ko) 췌장염 등에 대한 치료제
NO950177L (no) Farmakologisk aktive erivater
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
IE890943L (en) Agents for preserving or restoring the soundness of the skin
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
ES2011271B3 (es) Desinfectantes para cuartos de baño.
UA27784C2 (uk) Шипуча фармацевтична композиція для орального введення
CO4930293A1 (es) Derivados de 5-triazolil-2,3(1h,4h)-quinoxalinadiona que son antagonistas selectivos de receptores de n-metil-d-aspartato
FR2691630B1 (fr) Composition pharmaceutique, en particulier pour l'administration orale, contenant, comme ingrédient actif, un agoniste sélectif des récepteurs de type 5HT1.
ATE165737T1 (de) Pharmazeutische zusammensetzungen, die 5-ht 1- rezeptoragonisten und absorptionsverstärker enthalten

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100831